CRH Cash & Equivalents decreased by 20.9% to $3.24B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.3%, from $3.35B to $3.24B. Over 4 years (FY 2021 to FY 2025), Cash & Equivalents shows a downward trend with a -8.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher levels indicate strong liquidity and financial flexibility; lower levels may signal potential cash flow issues.
This represents the most liquid assets held by the company, including cash on hand, demand deposits, and short-term inve...
A universal metric for assessing a company's immediate financial health.
cash_and_equivalents| Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.78B | $5.94B | $4.65B | $4.28B | $5.72B | $6.34B | $3.31B | $3.07B | $2.98B | $3.72B | $3.35B | $2.88B | $4.20B | $4.10B | $3.24B |
| QoQ Change | — | +2.6% | -21.7% | -8.1% | +33.8% | +10.8% | -47.8% | -7.3% | -2.9% | +24.9% | -9.9% | -14.2% | +46.0% | -2.4% | -20.9% |
| YoY Change | — | +2.6% | — | — | — | +6.8% | -28.9% | -28.3% | -48.0% | -41.3% | +1.3% | -6.2% | +41.0% | +10.1% | -3.3% |